This grant from the National Institute on Drug Abuse aims to accelerate the development of Digital Therapeutics (DTx) for treating Substance Use Disorders (SUDs). The funding opportunity seeks to support the advancement of clinical-grade mobile, web, or software-based platforms that deliver safe and effective treatments for SUD. The primary goal is to progress DTx towards FDA authorization, ultimately increasing access to treatment for patients with SUD. Applications can focus on pre-clinical or clinical development and testing of new or existing DTx for SUDs. Closing date for submissions is December 6, 2023.
Opportunity ID: 332311
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-183 |
| Funding Opportunity Title: | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 23, 2021 |
| Last Updated Date: | Apr 01, 2021 |
| Original Closing Date for Applications: | Jan 10, 2024 |
| Current Closing Date for Applications: | Dec 06, 2023 |
| Archive Date: | Jan 05, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses State governments Small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-183.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated expiration date in accordance with NOT-DA-21-042 | Apr 01, 2021 | |
| Mar 23, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-183 |
| Funding Opportunity Title: | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 23, 2021 |
| Last Updated Date: | Apr 01, 2021 |
| Original Closing Date for Applications: | Jan 10, 2024 |
| Current Closing Date for Applications: | Dec 06, 2023 |
| Archive Date: | Jan 05, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses State governments Small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-183.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-183 |
| Funding Opportunity Title: | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 23, 2021 |
| Last Updated Date: | Mar 23, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 10, 2024 |
| Archive Date: | Feb 15, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-183.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
Folder 332311 Full Announcement-PAR-21-183 -> PAR-21-183-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00266111 | Jul 04, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270463 | Nov 18, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278433 | Nov 15, 2022 | Dec 06, 2023 | View |
Package 1
Mandatory forms
332311 RR_SF424_2_0-2.0.pdf
332311 PHS398_CoverPageSupplement_5_0-5.0.pdf
332311 RR_OtherProjectInfo_1_4-1.4.pdf
332311 PerformanceSite_2_0-2.0.pdf
332311 RR_KeyPersonExpanded_2_0-2.0.pdf
332311 RR_Budget_1_4-1.4.pdf
332311 PHS398_ResearchPlan_4_0-4.0.pdf
332311 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332311 RR_SubawardBudget30_1_4-1.4.pdf
332311 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
332311 RR_SF424_5_0-5.0.pdf
332311 PHS398_CoverPageSupplement_5_0-5.0.pdf
332311 RR_OtherProjectInfo_1_4-1.4.pdf
332311 PerformanceSite_4_0-4.0.pdf
332311 RR_KeyPersonExpanded_4_0-4.0.pdf
332311 RR_Budget_3_0-3.0.pdf
332311 PHS398_ResearchPlan_4_0-4.0.pdf
332311 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332311 RR_SubawardBudget30_3_0-3.0.pdf
332311 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
332311 RR_SF424_5_0-5.0.pdf
332311 PHS398_CoverPageSupplement_5_0-5.0.pdf
332311 RR_OtherProjectInfo_1_4-1.4.pdf
332311 PerformanceSite_4_0-4.0.pdf
332311 RR_KeyPersonExpanded_4_0-4.0.pdf
332311 RR_Budget_3_0-3.0.pdf
332311 PHS398_ResearchPlan_5_0-5.0.pdf
332311 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332311 RR_SubawardBudget30_3_0-3.0.pdf
332311 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
